These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 32304127)
1. CD4 Imai N; Tawara I; Yamane M; Muraoka D; Shiku H; Ikeda H Cancer Sci; 2020 Jun; 111(6):1958-1968. PubMed ID: 32304127 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regression. Imai N; Ikeda H; Tawara I; Wang L; Wang L; Nishikawa H; Kato T; Shiku H Cancer Sci; 2009 Jul; 100(7):1317-25. PubMed ID: 19432889 [TBL] [Abstract][Full Text] [Related]
3. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size. Chiu YL; Lin CH; Sung BY; Chuang YF; Schneck JP; Kern F; Pawelec G; Wang GC Sci Rep; 2016 Jan; 6():19227. PubMed ID: 26778409 [TBL] [Abstract][Full Text] [Related]
6. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions. Asnagli H; Schmitt-Verhulst AM; Guimezanes A J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464 [TBL] [Abstract][Full Text] [Related]
7. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients. de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753 [TBL] [Abstract][Full Text] [Related]
8. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]
9. Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control. Hwang ML; Lukens JR; Bullock TN J Immunol; 2007 Nov; 179(9):5829-38. PubMed ID: 17947656 [TBL] [Abstract][Full Text] [Related]
10. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy. Hu HM; Winter H; Urba WJ; Fox BA J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058 [TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD. Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Lu J; Giuntoli RL; Omiya R; Kobayashi H; Kennedy R; Celis E Clin Cancer Res; 2002 Dec; 8(12):3877-84. PubMed ID: 12473603 [TBL] [Abstract][Full Text] [Related]
15. Human dendritic cells sequentially matured with CD4(+) T cells as a secondary signal favor CTL and long-term T memory cell responses. Simon T; Tanguy-Royer S; Royer PJ; Boisgerault N; Frikeche J; Fonteneau JF; Grégoire M Biol Res; 2012; 45(1):33-43. PubMed ID: 22688982 [TBL] [Abstract][Full Text] [Related]
16. CMV induces expansion of highly polyfunctional CD4+ T cell subset coexpressing CD57 and CD154. Pera A; Vasudev A; Tan C; Kared H; Solana R; Larbi A J Leukoc Biol; 2017 Feb; 101(2):555-566. PubMed ID: 27566833 [TBL] [Abstract][Full Text] [Related]
17. The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses. Ostrowski MA; Justement SJ; Ehler L; Mizell SB; Lui S; Mican J; Walker BD; Thomas EK; Seder R; Fauci AS J Immunol; 2000 Dec; 165(11):6133-41. PubMed ID: 11086046 [TBL] [Abstract][Full Text] [Related]
18. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy. Rolle CE; Carrio R; Malek TR Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768 [TBL] [Abstract][Full Text] [Related]
19. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors. Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141 [TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity. Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]